Table 1 Pertinent clinical and histological features of the 54 primary cutaneous melanomas included in the tissue microarray

From: Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma

Case no.

Sex

Age

Status

Type

T

Thickness (mm)

Ulceration

Regression

Mitotic rate

TILS

Mean securin

 1

f

78

AwRD

1

2A

1.34

+

2

2

24

 2

f

65

DOD

3

3A

3.74

2

1

0

 3

f

54

AwMD

2

4B

5.44

+

2

1

3.2

 4

f

57

DOD

1

1B

0.98

+

2

2

7

 5

f

75

AwRD

2

4B

7.58

+

2

1

63

 6

f

70

DOC

1

1A

0.82

+

1

1

10

 7

f

66

NED

1

3A

3.32

1

1

14

 8

f

67

DOD

3

4A

6.40

2

1

10

 9

m

72

DOD

2

3B

3.52

+

2

1

13.3

10

f

89

DOD

3

4B

7.04

+

2

0

14

11

f

77

DOC

1

3A

2.52

2

0

0

12

f

40

DOD

2

4B

10.88

+

2

0

35.5

13

f

76

DOD

2

4B

14.56

+

2

0

1.2

14

f

54

NED

2

3B

3.65

+

1

2

11.5

15

m

63

NED

1

3B

3.68

+

2

0

0

16

f

57

NED

1

1A

0.96

1

1

4

17

m

76

DOD

1

3B

2.21

+

1

1

0

18

f

74

NED

1

2A

1.59

+

2

2

0

19

f

92

NED

2

4B

4.70

+

2

1

0.8

20

f

93

NED

1

4B

6.72

+

2

0

2.2

21

f

65

DOD

1

2A

1.19

+

1

0

0

22

f

58

NED

1

2A

1.92

0

2

0

23

m

71

NED

2

4B

9.28

+

1

0

1

24

f

34

NED

1

1A

0.94

+

1

1

0

25

f

56

NED

2

3A

2.08

2

1

43.8

26

f

56

DOD

2

4B

8.16

+

2

0

12

27

f

37

DOD

1

2A

1.20

+

1

1

0

28

m

58

NED

1

3A

2.42

1

0

0

29

m

63

NED

4

4A

4.16

+

2

0

7.8

30

m

47

LOF

1

1A

0.66

0

0

0

31

m

38

DOD

1

4A

5.02

2

0

0.2

32

f

9

NED

4

4B

4.70

+

2

0

0

33

m

78

DOD

3

4B

14.18

+

2

0

4.8

34

m

74

AwRD

1

4A

5.18

1

1

0.4

35

f

68

DOD

1

3A

2.75

1

1

0.5

36

f

64

NED

2

4B

17.12

+

2

2

29.2

37

f

79

AwRD

2

4B

7.52

+

1

1

31.5

38

m

78

DOD

1

3B

3.04

+

1

2

16.6

39

f

1

DOD

2

4A

12.41

2

0

227

40

f

92

DOC

1

4B

6.81

+

1

2

39

41

f

47

NED

1

4A

4.61

+

1

2

0

42

m

63

DOC

1

4A

5.95

+

2

1

6

43

f

46

LOF

2

3A

2.08

1

2

0

44

m

33

NED

1

2A

1.54

1

1

16.3

45

f

55

DOD

3

3A

2.30

2

0

0

46

m

22

DOD

4

3A

3.36

2

1

17

47

f

64

NED

1

2A

1.44

+

1

2

0

48

f

72

DOD

2

4B

7.97

+

2

1

0

49

f

73

DOD

3

3B

3.36

+

2

1

0

50

m

85

DOD

4

4A

15.64

2

2

0

51

f

67

NED

1

3A

2.05

+

2

1

3

52

m

64

LOF

1

2A

1.40

+

1

1

3

53

f

53

NED

1

2A

1.02

1

0

2.6

54

f

56

DOD

2

4B

18.56

+

2

0

0

  1. Sex: f=female; m=male. Status: AwRD=alive with regional disease; AwMD=alive with metastatic disease; DOD=dead of disease; DOC=dead of other cause; NED=no evidence of disease; LOF=lost for follow-up. Type: histogenetic type; 1=superficial spreading type; 2=nodular type; 3=acrolentiginous type; 4=other types. T=tumour stage. Mitotic rate: 0=no mitoses; 1=<6/mm2; 2=>6/mm2; TILS=tumour-infiltrating lymphocytes; 0=no TILS; 1=nonbrisk infiltrate of TILS; 2=brisk infiltrate of TILS. Mean PTTG: mean number of cells with nuclear or cytoplasmic PTTG-staining, counted in the different cores of each melanoma.